The Effect of Semaglutide on Bone Health

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
OsteoporosisOsteoporosis FractureT2DM
Interventions
DRUG

semaglutide combined with metformin

The initial dose of semaglutide is 0.25 mg once weekly. After 4 weeks, the dose is adjusted to 0.5 mg once weekly. After another 4 weeks, the dose is adjusted to 1 mg once weekly. During the same period, they will take metformin (500mg each time, three times a day) for treatment. The treatment course is 12 months.

Trial Locations (1)

Unknown

The First Affiliated Hospital of Xiamen University, Xiamen

All Listed Sponsors
collaborator

Peking University First Hospital

OTHER

collaborator

Shanghai Punan Hospital of Pudong New District

OTHER

collaborator

Shanghai 6th People's Hospital

OTHER

collaborator

Jinzhou Medical University

OTHER

lead

The First Affiliated Hospital of Xiamen University

OTHER